Literature DB >> 18597398

A high interleukin 1 receptor antagonist/IL-1beta ratio occurs naturally in knee osteoarthritis.

Pascal Richette1, Mathias François, Eric Vicaut, Catherine Fitting, Thomas Bardin, Maïté Corvol, Jean-François Savouret, François Rannou.   

Abstract

OBJECTIVE: To assess the interleukin 1 receptor antagonist (IL-1Ra)/IL-1beta ratio in synovial fluid (SF) of patients with knee osteoarthritis (OA) or rheumatoid arthritis (RA) to determine a possible relation between cytokine level and disease activity.
METHODS: IL-1beta and IL-1Ra concentrations were measured by ELISA in knee SF from patients with OA (n = 42) or RA (n = 11). For OA patients, pain and disability were assessed by a visual analog scale (VAS) and the Lequesne index. RA disease activity was assessed using the Disease Activity Score 28 Joint Count (DAS28).
RESULTS: Patients with OA showed lower median levels of IL-1beta and IL-1Ra in SF than patients with RA (p < 0.001) but a higher IL-1Ra/IL-1beta ratio: 1793 (584-6221) versus 773.5 (187.64-1570.5) (p = 0.05). For patients with OA, the IL-1Ra/IL-1beta ratio was not associated with pain or disability. For patients with RA, the IL-1Ra/IL-1beta ratio and IL-1Ra and IL-1beta levels were related to SF white blood cell count.
CONCLUSION: High endogenous IL-1Ra/IL-1beta ratio occurs in SF from knee OA and does not correlate with pain or Lequesne index. Our results suggest that intraarticular injection of IL-1Ra might be self-limited in patients with knee OA and a naturally high SF ratio.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18597398

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  18 in total

1.  Understanding Symptom Burden in Patients With Advanced Cancer Living in Rural Areas.

Authors:  Stephanie Gilbertson-White; Yelena Perkhounkova; Seyedehtanaz Saeidzadeh; Maria Hein; Rachel Dahl; Andrean Simons-Burnett
Journal:  Oncol Nurs Forum       Date:  2019-07-01       Impact factor: 2.172

2.  Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice.

Authors:  Jon Lampa; Marie Westman; Diana Kadetoff; Anna Nordenstedt Agréus; Erwan Le Maître; Caroline Gillis-Haegerstrand; Magnus Andersson; Mohsen Khademi; Maripat Corr; Christina A Christianson; Ada Delaney; Tony L Yaksh; Eva Kosek; Camilla I Svensson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-16       Impact factor: 11.205

Review 3.  Biologic agents in osteoarthritis: hopes and disappointments.

Authors:  Xavier Chevalier; Florent Eymard; Pascal Richette
Journal:  Nat Rev Rheumatol       Date:  2013-04-02       Impact factor: 20.543

Review 4.  A systems biology approach to synovial joint lubrication in health, injury, and disease.

Authors:  Alexander Y Hui; William J McCarty; Koichi Masuda; Gary S Firestein; Robert L Sah
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2011-08-08

Review 5.  Role of interleukin-1 inhibitors in osteoarthritis: an evidence-based review.

Authors:  Zdravko Jotanovic; Radovan Mihelic; Branko Sestan; Zlatko Dembic
Journal:  Drugs Aging       Date:  2012-05-01       Impact factor: 3.923

6.  Blocking ERK-1/2 reduces tumor necrosis factor alpha-induced interleukin-18 bioactivity in rheumatoid arthritis synovial fibroblasts by induction of interleukin-18 binding protein A.

Authors:  Hubert Marotte; Salahuddin Ahmed; Jeffrey H Ruth; Alisa E Koch
Journal:  Arthritis Rheum       Date:  2010-03

7.  Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection.

Authors:  Marijn Rutgers; Daniël B F Saris; Wouter J A Dhert; Laura B Creemers
Journal:  Arthritis Res Ther       Date:  2010-06-10       Impact factor: 5.156

Review 8.  Human genome-wide expression analysis reorients the study of inflammatory mediators and biomechanics in osteoarthritis.

Authors:  J D Sandy; D D Chan; R L Trevino; M A Wimmer; A Plaas
Journal:  Osteoarthritis Cartilage       Date:  2015-11       Impact factor: 6.576

9.  Plasma levels of interleukin-1 receptor antagonist (IL1Ra) predict radiographic progression of symptomatic knee osteoarthritis.

Authors:  M Attur; A Statnikov; J Samuels; Z Li; A V Alekseyenko; J D Greenberg; S Krasnokutsky; L Rybak; Q A Lu; J Todd; H Zhou; J M Jordan; V B Kraus; C F Aliferis; S B Abramson
Journal:  Osteoarthritis Cartilage       Date:  2015-11       Impact factor: 6.576

10.  Anticytokine therapy for osteoarthritis: evidence to date.

Authors:  Charles J Malemud
Journal:  Drugs Aging       Date:  2010-02-01       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.